Paper2775615
The effect of age on the pharmacokinetics of levodopa administered alone and in the presence of carbidopa.
Robertson DR and 6 others. Br J Clin Pharmacol, 1989. Cited by 85 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. The effect of age on the pharmacokinetics of levodopa administered alone and in the presence of carbidopa. Papers, record 2775615. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/2775615
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Aging | Major topic |
| Carbidopa | Major topic |
| Levodopa | Major topic |
| Administration, Oral | |
| Adult | |
| Aged | |
| Drug Interactions | |
| Female | |
| Humans | |
| Injections, Intravenous | |
| Male |
Source PubMed
References27
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 6,052,883 | The assessment of the amount of fat in the human body from measurements of skinfold thickness. | Br J Nutr | 1967 | https://conductscience.org/library/papers/6052883 | PubMed |
| 2 | 14,270,624 | THE EFFECT OF INCREASING AGE ON THE DISTRIBUTION OF PERIPHERAL BLOOD FLOW IN MAN. | J Am Geriatr Soc | 1965 | https://conductscience.org/library/papers/14270624 | PubMed |
| 3 | 5,459,997 | Adult lean body mass declines with age: some longitudinal observations. | Metabolism | 1970 | https://conductscience.org/library/papers/5459997 | PubMed |
| 4 | 5,100,498 | Incidence of side effects from levodopa during the introduction of treatment. | Br Med J | 1971 | https://conductscience.org/library/papers/5100498 | PubMed |
| 5 | 5,171,067 | Absorption and metabolism of levodopa. | JAMA | 1971 | https://conductscience.org/library/papers/5171067 | PubMed |
| 6 | 5,061,285 | Catecholamine metabolism during oral administration of levodopa. | Arch Neurol | 1972 | https://conductscience.org/library/papers/5061285 | PubMed |
| 7 | 4,686,016 | Effects of L-dopa administration of the concentrations of dopa, dopamine and norepinephrine in various rat tissues. | J Pharmacol Exp Ther | 1973 | https://conductscience.org/library/papers/4686016 | PubMed |
| 8 | 4,702,182 | Levodopa for parkinsonism in elderly and demented patients. | Med J Aust | 1973 | https://conductscience.org/library/papers/4702182 | PubMed |
| 9 | 4,528,851 | Variability of L-dopa absorption in man. | Aust N Z J Med | 1974 | https://conductscience.org/library/papers/4528851 | PubMed |
| 10 | 4,418,704 | Effects of levodopa therapy in patients with Parkinson's disease: statistical evidence for reduced tolerance to levodopa in the elderly. | J Am Geriatr Soc | 1974 | https://conductscience.org/library/papers/4418704 | PubMed |
| 11 | 1,123,640 | Fluctuations in DOPA decarboxylase activity with age. | J Neurochem | 1975 | https://conductscience.org/library/papers/1123640 | PubMed |
| 12 | 1,164,821 | Commentary: a physiological approach to hepatic drug clearance. | Clin Pharmacol Ther | 1975 | https://conductscience.org/library/papers/1164821 | PubMed |
| 13 | 782,834 | Levodopa and decarboxylase inhibitors: a review of their clinical pharmacology and use in the treatment of parkinsonism. | Drugs | 1976 | https://conductscience.org/library/papers/782834 | PubMed |
| 14 | 759,567 | Brain tissue and plasma assay of L-DOPA and alpha-methyldopa metabolites by high performance liquid chromatography with electrochemical detection. | J Neurochem | 1979 | https://conductscience.org/library/papers/759567 | PubMed |
| 15 | 391,463 | Drug kinetics and hepatic blood flow. | Clin Pharmacokinet | 1979 | https://conductscience.org/library/papers/391463 | PubMed |
| 16 | 7,363,934 | Systemic activity of orally administered L-dopa in the elderly Parkinson patient. | Eur J Clin Pharmacol | 1980 | https://conductscience.org/library/papers/7363934 | PubMed |
| 17 | 7,246,340 | Senile parkinsonism, a study of current treatment. | Age Ageing | 1981 | https://conductscience.org/library/papers/7246340 | PubMed |
| 18 | 7,264,915 | Dosage form design for improvement of bioavailability of levodopa IV: Possible causes of low bioavailability of oral levodopa in dogs. | J Pharm Sci | 1981 | https://conductscience.org/library/papers/7264915 | PubMed |
| 19 | 7,202,139 | Gastric emptying rate and the systemic availability of levodopa in the elderly parkinsonian patient. | Neurology | 1981 | https://conductscience.org/library/papers/7202139 | PubMed |
| 20 | 6,660,139 | Diagnosis and management of parkinsonism in the elderly. | Age Ageing | 1983 | https://conductscience.org/library/papers/6660139 | PubMed |
Cited by44
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 85 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41,172,985 | Bioengineered gut bacterium synthesizing levodopa alleviates motor deficits in models of Parkinson's disease. | Cell Host Microbe | 2025 | https://conductscience.org/library/papers/41172985 | PubMed |
| 40,483,284 | Development of an in-situ forming implant system for levodopa and carbidopa for the treatment of parkinson's disease. | Drug Deliv Transl Res | 2025 | https://conductscience.org/library/papers/40483284 | PubMed |
| 40,464,628 | The Treatment of Older Patients with Parkinson's Disease. | Dtsch Arztebl Int | 2025 | https://conductscience.org/library/papers/40464628 | PubMed |
| 38,905,055 | Impact of Physical Exercise on Levodopa Therapy Across Parkinson's Disease Stages. | J Parkinsons Dis | 2024 | https://conductscience.org/library/papers/38905055 | PubMed |
| 36,309,950 | Effect of Carbidopa Dose on Levodopa Pharmacokinetics With and Without Catechol-O-Methyltransferase Inhibition in Healthy Subjects. | Eur J Drug Metab Pharmacokinet | 2023 | https://conductscience.org/library/papers/36309950 | PubMed |
| 35,541,045 | Simultaneous electrochemical determination of levodopa and piroxicam using a glassy carbon electrode modified with a ZnO-Pd/CNT nanocomposite. | RSC Adv | 2018 | https://conductscience.org/library/papers/35541045 | PubMed |
| 32,477,245 | Dopamine Buffering Capacity Imaging: A Pharmacodynamic fMRI Method for Staging Parkinson Disease. | Front Neurol | 2020 | https://conductscience.org/library/papers/32477245 | PubMed |
| 31,781,365 | Patterns and Determinants of Prescribing for Parkinson's Disease: A Systematic Literature Review. | Parkinsons Dis | 2019 | https://conductscience.org/library/papers/31781365 | PubMed |
| 31,681,153 | Contributions of Gut Bacteria and Diet to Drug Pharmacokinetics in the Treatment of Parkinson's Disease. | Front Neurol | 2019 | https://conductscience.org/library/papers/31681153 | PubMed |
| 31,258,882 | Pharmacokinetics and tolerability of inhaled levodopa from a new dry-powder inhaler in patients with Parkinson's disease. | Ther Adv Chronic Dis | 2019 | https://conductscience.org/library/papers/31258882 | PubMed |
| 30,847,947 | Vasodilation through levodopa for Parkinson's disease may require high left ventricular assist device flow. | J Card Surg | 2019 | https://conductscience.org/library/papers/30847947 | PubMed |
| 28,236,251 | Pharmacokinetics of Rytary®, An Extended-Release Capsule Formulation of Carbidopa-Levodopa. | Clin Pharmacokinet | 2017 | https://conductscience.org/library/papers/28236251 | PubMed |
| 28,101,657 | Levodopa/carbidopa microtablets in Parkinson's disease: a study of pharmacokinetics and blinded motor assessment. | Eur J Clin Pharmacol | 2017 | https://conductscience.org/library/papers/28101657 | PubMed |
| 27,247,848 | Causes and factors related to dopamine agonist withdrawal in Parkinson's disease. | Brain Behav | 2016 | https://conductscience.org/library/papers/27247848 | PubMed |
| 26,779,024 | The Human Experience with Intravenous Levodopa. | Front Pharmacol | 2015 | https://conductscience.org/library/papers/26779024 | PubMed |
| 26,336,641 | Orthostatic stability with intravenous levodopa. | PeerJ | 2015 | https://conductscience.org/library/papers/26336641 | PubMed |
| 25,838,754 | Effects of Parkinson's Disease on Fundamental Frequency Variability in Running Speech. | J Med Speech Lang Pathol | 2013 | https://conductscience.org/library/papers/25838754 | PubMed |
| 25,413,723 | Empirical and semi-mechanistic modelling of double-peaked pharmacokinetic profile phenomenon due to gastric emptying. | AAPS J | 2015 | https://conductscience.org/library/papers/25413723 | PubMed |
| 24,631,952 | Preventive effect of rikkunshito on gastric motor function inhibited by L-dopa in rats. | Peptides | 2014 | https://conductscience.org/library/papers/24631952 | PubMed |
| 24,433,449 | Population pharmacokinetics of levodopa in subjects with advanced Parkinson's disease: levodopa-carbidopa intestinal gel infusion vs. oral tablets. | Br J Clin Pharmacol | 2014 | https://conductscience.org/library/papers/24433449 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/2775615
GET https://conductscience.org/api/papers/v1/2775615/references?page=2